GSK Says Bepirovirsen Achieves Phase III Functional Cure Goal In Chronic Hepatitis B
28/5 18:39
(RTTNews) - Drugmaker GSK plc (GSK) on Tuesday announced positive Phase III trial results for investigational hepatitis B treatment bepirovirsen....
28/5 18:39
(RTTNews) - Drugmaker GSK plc (GSK) on Tuesday announced positive Phase III trial results for investigational hepatitis B treatment bepirovirsen....